On the Role of Islet Amyloid Polypeptide in Glucose Intolerance and Anorexia of Pancreatic Cancer
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Pancreatology
- Vol. 1 (3) , 267-274
- https://doi.org/10.1159/000055822
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Pancreatic CancerDrugs, 2000
- Multiple Ramp Domains Are Required for Generation of Amylin Receptor Phenotype from the Calcitonin Receptor Gene ProductBiochemical and Biophysical Research Communications, 2000
- Increased Insulin Secretion and Glucose Tolerance in Mice Lacking Islet Amyloid Polypeptide (Amylin)Biochemical and Biophysical Research Communications, 1998
- Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPα) in the fasted, anaesthetized ratLife Sciences, 1993
- Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized ratsBiochemical and Biophysical Research Communications, 1991
- Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreasBiochemical and Biophysical Research Communications, 1990
- Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreasBiochemical and Biophysical Research Communications, 1990
- The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in catsBiochemical and Biophysical Research Communications, 1990
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986
- A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinomaDigestive Diseases and Sciences, 1978